BNP Paribas Issuance News - P14XS8

Actavis Changes Name to Allergan After Deal For Botox Maker

By Neil Haggerty Actavis PLC said Monday it has changed its name to Allergan PLC, three months after acquiring the maker of the antiwrinkle...

BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educatio

MADISON HEIGHTS, Mich., Dec. 4 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today...

UPDATE: Allergan 3Q Profit Rises 8.3% With Botox Help

(Updates throughout with details on results, recent Botox filings, CEO and analyst comments, updated share price.) By Jon Kamp Of DOW JONES...

CORRECT: Allergan 3Q Net Up 8.3% Amid Cost Cuts; View Raised

("Allergan 3Q Net Up 8% Amid Cost Cuts; 2009 View Raised," published at 9:41 a.m. EDT, incorrectly noted earnings including noncontrolling...

BioMarin, Human Genome Lead US Drug Stocks Higher

By Val Brickates Kennedy U.S. drug stocks edged higher in early trading Thursday, with shares of biotech groups BioMarin Pharmaceutical Inc. and...

Allergan 3Q Net Up 8% Amid Cost Cuts; 2009 View Raised

Allergan Inc.'s (AGN) third-quarter profit rose 8% on higher sales and margins at the eye- and skin-care products company. The maker of Botox and...

UPDATE: Allergan Sees Suit Against Government As Unique To Company

Allergan Inc. (AGN) officials said Friday the drug maker's lawsuit against the government, seeking the right to discuss unapproved uses of its...

Allergan Sees Suit Against Government As Unique To Company

Allergan Inc. (AGN) officials said Friday that a lawsuit filed against the government regarding the company's ability to discuss unapproved uses...

Critical Alerts for Apple, Alcoa, CarMax, Allergan, and AnnTaylor Released by Seven Summits Research

CHICAGO, Sept. 29 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for AAPL, AA, KMX, AGN, and ANN. Seven Summits Strategic...

FDA Warns Allergan About Web Site For Eyelash Thickener

The Web site of Allergan Inc.'s (AGN) Latisse is misleading because it suggests the company's eyelash thickener is more safe than proven, federal...

2nd UPDATE: Two Studies Show Botox Helps Against Migraines

(Adds backround in paragraph 6, updates share price.) By Jon Kamp Of DOW JONES NEWSWIRES Details from two studies examining Allergan Inc.'s (AGN...

UPDATE: Two Studies Show Botox Helps Against Migraines

(Adds details on share price in paragraph 4, company comment in paragraph 8.) By Jon Kamp Of DOW JONES NEWSWIRES Details from two studies...

Studies Show Allergan's Botox Helping Against Migraines

By Jon Kamp Of DOW JONES NEWSWIRES Details from two studies examining Allergan Inc.'s (AGN) wrinkle fighter Botox as a chronic migraine headache...

FDA: Allergan Ad Misrepresents Acne Medicine's Effectiveness

A journal advertisement for Allergan Inc.'s (AGN) acne cream, Aczone, overstates the medicine's effectiveness and omits key safety information...

FDA Signs Off On Botox Warning; Changes Generic Name

The Food and Drug Administration said Monday it approved a new warning on Allergan Inc.'s (AGN) Botox and a similar product about the possibility...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

BNP Paribas Issuance (P14XS8)

Empower your portfolio: Real-time discussions and actionable trading ideas.

P14XS8 News

Actavis Changes Name to Allergan After Deal For Botox Maker

BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educatio

UPDATE: Allergan 3Q Profit Rises 8.3% With Botox Help

CORRECT: Allergan 3Q Net Up 8.3% Amid Cost Cuts; View Raised

BioMarin, Human Genome Lead US Drug Stocks Higher

Allergan 3Q Net Up 8% Amid Cost Cuts; 2009 View Raised

UPDATE: Allergan Sees Suit Against Government As Unique To Company

Allergan Sees Suit Against Government As Unique To Company

Critical Alerts for Apple, Alcoa, CarMax, Allergan, and AnnTaylor Released by Seven Summits Research

FDA Warns Allergan About Web Site For Eyelash Thickener

2nd UPDATE: Two Studies Show Botox Helps Against Migraines

UPDATE: Two Studies Show Botox Helps Against Migraines

Studies Show Allergan's Botox Helping Against Migraines

FDA: Allergan Ad Misrepresents Acne Medicine's Effectiveness

FDA Signs Off On Botox Warning; Changes Generic Name

P14XS8 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

BNP Paribas Issuance (P14XS8) News

BNP Paribas Issuance (P14XS8)

Empower your portfolio: Real-time discussions and actionable trading ideas.

P14XS8 News

Actavis Changes Name to Allergan After Deal For Botox Maker

BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educatio

UPDATE: Allergan 3Q Profit Rises 8.3% With Botox Help

CORRECT: Allergan 3Q Net Up 8.3% Amid Cost Cuts; View Raised

BioMarin, Human Genome Lead US Drug Stocks Higher

Allergan 3Q Net Up 8% Amid Cost Cuts; 2009 View Raised

UPDATE: Allergan Sees Suit Against Government As Unique To Company

Allergan Sees Suit Against Government As Unique To Company

Critical Alerts for Apple, Alcoa, CarMax, Allergan, and AnnTaylor Released by Seven Summits Research

FDA Warns Allergan About Web Site For Eyelash Thickener

2nd UPDATE: Two Studies Show Botox Helps Against Migraines

UPDATE: Two Studies Show Botox Helps Against Migraines

Studies Show Allergan's Botox Helping Against Migraines

FDA: Allergan Ad Misrepresents Acne Medicine's Effectiveness

FDA Signs Off On Botox Warning; Changes Generic Name

P14XS8 Discussion

Your Recent History